Artiva Biotherapeutics News

TD Cowen Maintains Artiva Biotherapeutics(ARTV.US) With Buy Rating

Futu NewsSep 3 18:31

Artiva Biotherapeutics Analyst Ratings

BenzingaAug 30 23:59

Needham Reiterates Buy on Artiva Biotherapeutics, Maintains $23 Price Target

BenzingaAug 30 23:59

Wedbush Maintains Artiva Biotherapeutics(ARTV.US) With Buy Rating, Maintains Target Price $18

Futu NewsAug 30 22:31

Artiva Biotherapeutics, Inc. (ARTV) Receives a Buy From Wedbush

TipRanksAug 30 22:11

Needham Maintains Artiva Biotherapeutics(ARTV.US) With Buy Rating, Maintains Target Price $23

Futu NewsAug 30 21:32

Buy Rating Affirmed for Artiva Biotherapeutics Amidst Clinical Advancements and Strong Financials

TipRanksAug 30 21:28

A Quick Look at Today's Ratings for Artiva Biotherapeutics(ARTV.US), With a Forecast Between $18 to $23

Futu NewsAug 14 21:00

A Quick Look at Today's Ratings for Artiva Biotherapeutics(ARTV.US), With a Forecast Between $18 to $23

Futu NewsAug 13 21:00

Artiva Biotherapeutics Price Target Announced at $23.00/Share by Cantor Fitzgerald

Dow JonesAug 13 19:36

Artiva Biotherapeutics Analyst Ratings

BenzingaAug 13 18:42

Jefferies Initiates Artiva Biotherapeutics at Buy With $21 Price Target

MT NewswiresAug 13 18:41

Analysts Offer Insights on Healthcare Companies: Artiva Biotherapeutics, Inc. (ARTV), BioMarin Pharmaceutical (BMRN) and Maravai Lifesciences Holdings (MRVI)

TipRanksAug 13 17:17